This story was originally published by CalMatters. Sign up for their newsletters. By Alexei Koseff and Kristen Hwang, CalMatters Gov. Gavin Newsom announced today that he will seek to regulate ...

We recently published a list of 8 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at ...

In a news release, Guthrie, the comitteee chair, heralded the committee’s plan, (which also cuts in green energy and other ...

Bucks County officials announced they are suing major insulin manufacturers and companies that negotiate drug price deals for ...

Squeezed by insurers and middlemen, independent pharmacists such as Jolley find themselves on the front lines of a tariff ...

Wyoming’s senior U.S. Sen. John Barrasso also is a medical doctor who says out-of-control drug prices are a real concern for ...

For decades, Americans have been overpaying for prescriptions and subsidizing innovation for the rest of the world. The White ...

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win over its rival. | A federal jury in Delaware has ...

Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...

Bristol Myers CEO Christopher Boerner advocates global cost-sharing for drug R&D and criticizes PBMs. Read nore here.

Some Iowa pharmacies say they’re on the verge of closing, and they’re putting their hopes on a bill advancing to the governor ...